Price
405.45
+4.22%52W Range
Market Cap
₹486.66 Cr
Traded: ₹0.83 Cr (0.17%) 0.0x
Free Float: ₹98.60 Cr (0.84% of FF traded)
Volume · 60D trend
20.8 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -- | -- | +14.0% | -- |
| Profit | -- | -- | -- | -- | +13.0% | -- |
| Return | -- | -- | -2.0% | -16.0% | -- | Decelerating |
| ROE | -- | -- | +18.0% | -- | -- | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19 | 19 | 18 | 19 | 16 | 18 | 15 | 16 | 13 | 16 | 14 | 13 | 13 |
| Expenses | 12 | 12 | 13 | 12 | 10 | 12 | 10 | 10 | 9 | 10 | 9 | 9 | 8 |
| Operating Profit | 7 | 7 | 6 | 7 | 5 | 7 | 5 | 6 | 5 | 6 | 4 | 4 | 5 |
| OPM % | 35.5% | 36.5% | 31.4% | 35.8% | 33.7% | 35.5% | 34.9% | 35.7% | 33.8% | 37.0% | 32.9% | 33.5% | 37.0% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 8 | 8 | 6 | 7 | 6 | 7 | 6 | 6 | 5 | 6 | 5 | 5 | 5 |
| Tax % | 25.4% | 25.5% | 26.7% | 24.8% | 26.4% | 28.1% | 22.2% | 24.6% | 25.1% | 25.1% | 23.2% | 26.2% | 24.3% |
| Net Profit | 6 | 6 | 5 | 6 | 4 | 5 | 5 | 5 | 4 | 5 | 4 | 4 | 4 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 4.7 | 4.8 | 3.9 | 4.6 | 3.7 | 4.3 | 3.8 | 4.0 | 3.1 | 4.0 | 3.0 | 3.0 | 3.4 |
| Sales Growth (YoY) | 20.9% | 2.7% | 23.5% | 14.6% | 18.0% | 13.6% | 9.8% | 23.4% | -0.2% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -- | 2.6% | -1.0% | 18.2% | -14.5% | 23.4% | -8.1% | 21.8% | -17.7% | 19.2% | 3.3% | -1.6% | -- |
| OP Growth (YoY) | 27.3% | 5.7% | 11.3% | 15.0% | 17.5% | 9.0% | 16.3% | 31.7% | -8.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | -2.2% | 19.1% | -13.2% | 25.8% | -18.8% | 25.5% | -10.3% | 28.5% | -24.7% | 33.9% | 1.6% | -11.1% | -- |
| Profit Growth (YoY) | -- | 13.2% | 4.2% | 14.9% | 20.2% | 7.8% | 24.4% | 32.4% | -10.1% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | 13.3% | 4.2% | 14.9% | 19.9% | 7.8% | 24.4% | 32.7% | -10.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 23.4% | -14.9% | 25.9% | -14.3% | 13.5% | -6.2% | 31.4% | -22.9% | 31.0% | 0.0% | -10.9% | -- |
| OP Margin | -- | 36.5% | 31.4% | 35.8% | 33.7% | 35.5% | 34.9% | 35.7% | 33.8% | 37.0% | 32.9% | 33.5% | 37.0% |
| Net Margin | -- | 30.7% | 25.6% | 29.7% | 28.0% | 27.9% | 30.3% | 29.6% | 27.5% | 29.4% | 26.7% | 27.6% | 30.5% |
| Material Cost % | 22.5% | 20.9% | 20.3% | 25.4% | 22.5% | 13.3% | 21.9% | 22.8% | 21.0% | 22.4% | 22.3% | 26.3% | 25.7% |
| Employee Cost % | 19.8% | 18.1% | 18.8% | 17.6% | 19.4% | 15.7% | 19.3% | 17.8% | 20.1% | 15.8% | 18.5% | 18.1% | 17.9% |
| P/S | 6.49 | 6.35 | 6.87 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 22.40 | 22.24 | 24.73 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.89 | 3.65 | 4.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Newspaper Publication regarding 27th Annual General Meeting and remote E-Voting information
The Company has sent letter to the shareholders for AGM whose email id was not registered with RTA.
Please find enclosed herewith Annual Report for Financial year 25-26.
27th AGM of the Company is scheduled to be held on Thursday, September 17, 2026 at 12:30 p.m. through VC/OAVM.
Newspaper Advertisement for Notice of AGM to be held through VC/OAVM.
The Company at its Board Meeting held today i.e. August 11, 2026 have approved Unaudited Financial Results of the Company (standalone and consolidated) for quarter ended June 30, 2026 and ....
The Board of Directors at its Meeting held today i.e. August 11, 2026 have considered and approved the unaudited financial results of the Company (standalone and consolidated) for quarter ....
Notice of Record Date.
Press Release regarding Financial Results of the Company for the quarter ended June 30, 2026, along with the declaration of dividend at the rate of 10% i.e. Rs. 1/- per Equity Share.
Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for quarter ended June 30, 2026
Transcript for Earning''s call held on 29th June, 2026
Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read along with SEBI (Listing Obligations & Disclosure Requirements) (Second ....
Investor Presentation to be made to Analysts/Investor on the Financial Results for financial year ended March 31, 2026
Intimation of Closure of Trading Window.
Intimation of Earnings Discussion is rescheduled to be held on June 29, 2026 at 03:00 p.m.
Non-Applicability of Annual Secretarial Compliance Report for the Financial year ended March 31, 2026
This is to inform you that the Earnings conference call scheduled to be held on June 02, 2026 has been cancelled due to unforeseen circumstances.
The Board of Directors at its Meeting held today have approved Audited Financial Results of the Company for quarter and financial year ended March 31, 2026
Audited Financial Results of the Company for quarter and financial year ended March 31, 2026
The Company at its meeting held today i.e., May 27, 2026 has appointed Mr. Sukhen Pal Babuta as Additional Director (Non Executive Independent Director) of the Company.
The Company at its meeting held today i.e., May 27, 2026, has appointed Mr. Pratul Gupta as Company Secretary and Compliance Officer of the Companty
The Company has appointed M/s. ADV & Associates, Chartered Accountants as Statutory Auditor of the Company for a period of 5 years, subject to approval of Members of the Company.
The Company at its meeting held today i.e., May 27, 2026 has appointed Internal Auditor, Cost Auditor, Secretarial Auditor and Statutory Auditor of the Company.
Intimation of Analyst / Institutional Investor Meeting to be held on, Tuesday, 02nd June 2026 at 4.00 PM.
Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Audited Financial Results of ....
The Board of Directors has approved subscription to the share capital of Prevest Denpro Gulf General Trading LLC, a wholly owned subsidiary for a amount upto AED 5,00,000 to be invested ....
Cessation of Mr. Pardeep Gandotra as Independent Director of the Company due to completion of tenure.
Appointment of Mr. Piyush Kiranprakash Gupta and Mr. Abhijeet Sadashiv Haridas as Additional Directors in the capacity of Non-Executive Independent Director.
Cessation of Mr. Sudeep Murthy and Mr. Nikhil Shrikant Bobade as Independent Director of the Company due to completion of tenure.
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended March 31, 2026.
Resignation of Mr. Aman Sadhotra from the post of Company Secretary and Compliance officer w.e.f April 06, 2026.
Intimation of Closure of Trading Window
Disclosure under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Considered and approved the unaudited financial results of the Company for quarter ended December 31, 2025.
Considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2025
Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve the unaudited Financial Results ....
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading Window.
Transcipt of the Company''s Earning call held on November 20, 2025.
Please find enclosed the audio recording of the Company's Earnings Call held with Investors/Analysts on November 20, 2025, to discuss the financial performance of the Company for the half ....
Intimation of Revised Schedule of Analyst / Institutional Investor Earnings Call under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation regarding postponement of Analyst/ Institutional Investor Earnings Call due to unforeseen work exigencies.
Investor Presentation to be made to Analysts/Investors
Earnings Discussion is scheduled to be held on, Monday, 17th November 2025 at 4.00 PM.
Unaudited Financial results of the Company for the quarter ended September 30, 2025
Outcome of the Board Meeting held on Wednesday, November 12, 2025 pursuant to Regulations 30, 33 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) ....
Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the unaudited financial results ....
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Intimation regardind closure of trading window
Concalls
18Nov 2025
30 Nov 2025Jun 2025
30 Jun 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Feb 2022
28 Feb 2022Dec 2021
31 Dec 2021